A Study of LY900014 in Participants With Type 2 Diabetes on Insulin Injection Therapy

Clinical trial NCT02703337 · COMPLETED

Trial details

NCT number: NCT02703337
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2016-03-01
Primary completion: 2016-08-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.